Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
1 Pogledi
• 07/04/23
0
0
Ugraditi
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari